Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Change in Accured Expenses (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Change in Accured Expenses of $1.1 million for Q1 2026, up 436.05% year-over-year from $209877.6 in Q1 2025, and up 514.37% quarter-over-quarter from -$271503.8 in Q4 2025.

Analysis

Oculis Holding AG (OCS) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 436.05% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at -$832893.9 (down 105.56% YoY), while the FY2025 annual figure was -$2.3 million, down 121.96% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at $1.1 million, up from -$271503.8 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $6.7 million in Q2 2024, with the low at -$5.8 million in Q1 2023.
  • The 5-year median for Change in Accured Expenses is $890610.0 (2023), against an average of $275292.4.
  • The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses tumbled 142.73% in 2025, then surged 436.05% in 2026.
  • Oculis Holding AG's Change in Accured Expenses stood at $2.5 million in 2022, then sank by 64.62% to $890610.0 in 2023, then soared by 312.08% to $3.7 million in 2024, then slumped by 107.4% to -$271503.8 in 2025, then jumped by 514.37% to $1.1 million in 2026.
  • Business Quant data shows OCS's Change in Accured Expenses at $1.1 million in Q1 2026, -$271503.8 in Q4 2025, and $1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.13 Mn
Dec 31, 2025 -271,503.84
Sep 30, 2025 1.17 Mn
Jun 30, 2025 -2.86 Mn
Mar 31, 2025 -334,787.41
Dec 31, 2024 3.67 Mn
Sep 30, 2024 4.95 Mn
Jun 30, 2024 6.69 Mn
Mar 31, 2024 -4.76 Mn
Dec 31, 2023 890,610.03
Sep 30, 2023 1.33 Mn
Jun 30, 2023 -4.88 Mn
Mar 31, 2023 -5.83 Mn
Dec 31, 2022 2.52 Mn
Sep 30, 2022 716,535.99